NCT03575949View on ClinicalTrials.gov

Standard and Delayed FDG PET/CT After Chemoradiation Therapy in Assessing Patients With Metastatic Head and Neck Squamous Cell Cancer

NACompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

June 15, 2018

Primary Completion Date

May 10, 2024

Study Completion Date

May 10, 2024

Conditions
Metastatic Head and Neck Squamous Cell CarcinomaMetastatic Malignant Neoplasm in the Spine
Interventions
PROCEDURE

Computed Tomography

Undergo FDG PET/CT

OTHER

Fludeoxyglucose F-18

Given IV

PROCEDURE

Positron Emission Tomography

Undergo FDG PET/CT

Trial Locations (1)

77030

M D Anderson Cancer Center, Houston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

M.D. Anderson Cancer Center

OTHER

NCT03575949 - Standard and Delayed FDG PET/CT After Chemoradiation Therapy in Assessing Patients With Metastatic Head and Neck Squamous Cell Cancer | Biotech Hunter | Biotech Hunter